Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 52.05
+1.65 (3.27%)
Sep 30, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 9.83 billion as of September 29, 2026. Its market cap has decreased by -25.14% in one year.
Market Cap
9.83B
Enterprise Value
8.83B
Revenue
246.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.05
ChartMarket Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 9.83B, a decrease of -24.20%. That is a compound annual growth rate of -20.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 10.16B | 0.12% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HBM Holdings | 11.33B |
| Ascentage Pharma Group International | 10.84B |
| GenFleet Therapeutics (Shanghai) | 10.15B |
| Everest Medicines | 9.97B |
| Ascletis Pharma | 9.03B |
| Suzhou Ribo Life Science | 8.72B |
| CStone Pharmaceuticals | 8.19B |
| Alphamab Oncology | 7.75B |